GE Healthcare, the healthcare business of GE (NYSE:GE), announced on Monday an agreement with ulrich GmbH & Co KG (ulrich medical) to offer a GE Healthcare branded contrast media injector in the United States.
Based in Germany, ulrich medical develops, produces and distributes spinal systems and contrast medium injectors.
GE Healthcare's CT motion multi-dose syringeless injector, which delivers iodinated contrast media for Computed Tomography (CT) imaging procedures, is designed to reduce procedure setup time and increase patient throughput by eliminating time consuming preparation steps, while helping to optimise patient dosing and reduce wasted contrast media.
New research shows savings of up to three minutes and 30mL of contrast media per patient procedure with the CT motion versus a typical syringe-based injector, GE said.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients